Asterias stem cell therapy shows promise in spinal cord paralysis -U.S. study – Thomson Reuters Foundation
The Express Tribune |
Asterias stem cell therapy shows promise in spinal cord paralysis -U.S. study
Thomson Reuters Foundation NEW YORK, Sept 14 (Reuters) – An experimental stem cell therapy developed by Asterias Biotherapeutics restored some movement to patients paralyzed by recent spinal cord injuries, according to interim data from a small study being presented on … What We're Looking For From The Upcoming Asterias Biotherapeutics Inc (NYSEMKT:AST) Presentation |
